These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17094906)

  • 1. [Mediastinal lymph node staging in non-small cell lung cancer: comparison between spiral computed tomographic findings and pathology].
    Zheng L; Wu PH; Mo YX; Xie CM; Ruan CM; Li L; Shen JX; Rong TH; Wang X; Zhang SY
    Ai Zheng; 2006 Nov; 25(11):1384-8. PubMed ID: 17094906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
    Yang WF; Tan GZ; Fu Z; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective comparison of CT versus mediastinoscopy in preoperative evaluation of mediastinal lymph node status in patients with non-small cell lung cancer].
    Wang X; Zheng L; Ling L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):42-4. PubMed ID: 19538868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Mediastinal Lymph Node Staging Techniques in the Preoperative Assessment of Nonsmall Cell Lung Cancer Patients.
    Fréchet B; Kazakov J; Thiffault V; Ferraro P; Liberman M
    J Bronchology Interv Pulmonol; 2018 Jan; 25(1):17-24. PubMed ID: 29261576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy.
    Aaby C; Kristensen S; Nielsen SM
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):279-85. PubMed ID: 8587782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
    Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
    Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging.
    Gupta NC; Tamim WJ; Graeber GG; Bishop HA; Hobbs GR
    Chest; 2001 Aug; 120(2):521-7. PubMed ID: 11502653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer.
    Moloney F; Ryan D; McCarthy L; McCarthy J; Burke L; Henry MT; Kennedy MP; Hinchion J; McSweeney S; Maher MM; O'Regan K
    Eur J Radiol; 2014 May; 83(5):843-7. PubMed ID: 24581594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer].
    Melek H; Günlüoğlu MZ; Demir A; Akin H; Medetoğlu B; Kara HV; Olçmen A; Dinçer SI
    Tuberk Toraks; 2008; 56(1):56-63. PubMed ID: 18330756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings.
    Bustos García de Castro A; Ferreirós Domínguez J; Delgado Bolton R; Fernández Pérez C; Cabeza Martínez B; García García-Esquinas M; Carreras Delgado JL
    Radiologia; 2017; 59(2):147-158. PubMed ID: 28238444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
    Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
    J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
    Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
    Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.
    Yasufuku K; Pierre A; Darling G; de Perrot M; Waddell T; Johnston M; da Cunha Santos G; Geddie W; Boerner S; Le LW; Keshavjee S
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1393-400.e1. PubMed ID: 21963329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.